The researchers concluded that oART, with BH technique, shows promise in reducing PTV margins and OAR doses in gastric ...

Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of ...

2020年1月20日，河北医科大学外科系在Oncotargets and Therapy（中科院四区 IF=2.7）刊上在线发表题为 "Silencing of LncRNA Metastasis-Associated Lung ...

New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of ...

The following is a summary of "Preoperative Chemoradiotherapy for Resectable Gastric Cancer," published in the September 2024 ...

The clinical trial and a new study mark a significant leap in the fight against gastric cancer with peritoneal spread. Read ...

In tandem with this breakthrough, a clinical trial has demonstrated the potential of an innovative treatment strategy ...

Despite improvement in pathologic complete response with preoperative chemoradiation, the benefit did not extend to overall ...

I-Mab (IMAB) said that an expanded Phase 1 monotherapy study of givastomig, a Claudin 18.2 X 4-1BB bispecific antibody ...

Oberotatug ravtansine is under clinical development by Oxford BioTherapeutics and currently in Phase I for Gastric Cancer.

Annexuzlimab is under clinical development by MedAnnex and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I drugs for Gastric Cancer have a 74% phase transition success rate ...

Lupin Limited partners with Takeda to launch Vonoprazan tablets in India, targeting acid peptic disorders with Lupivon brand.